Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Dur3 and nrt2 genes in the bloom-forming dinoflagellate Prorocentrum minimum: Transcriptional responses to available nitrogen sources.

Pechkovskaya SA, Knyazev NA, Matantseva OV, Emelyanov AK, Telesh IV, Skarlato SO, Filatova NA.

Chemosphere. 2019 Oct 9;241:125083. doi: 10.1016/j.chemosphere.2019.125083. [Epub ahead of print]

PMID:
31683425
2.

Self-adaptive STDP-based learning of a spiking neuron with nanocomposite memristive weights.

Emelyanov AV, Nikiruy KE, Serenko AV, Sitnikov AV, Presnyakov MY, Rybka RB, Sboev AG, Rylkov VV, Kashkarov PK, Kovalchuk MV, Demin VA.

Nanotechnology. 2020 Jan 17;31(4):045201. doi: 10.1088/1361-6528/ab4a6d. Epub 2019 Oct 2.

PMID:
31578002
3.

Beta-blockers in asthma: myth and reality.

Tiotiu A, Novakova P, Kowal K, Emelyanov A, Chong-Neto H, Novakova S, Labor M.

Expert Rev Respir Med. 2019 Sep;13(9):815-822. doi: 10.1080/17476348.2019.1649147. Epub 2019 Aug 2.

PMID:
31352857
4.

Parylene Based Memristive Devices with Multilevel Resistive Switching for Neuromorphic Applications.

Minnekhanov AA, Emelyanov AV, Lapkin DA, Nikiruy KE, Shvetsov BS, Nesmelov AA, Rylkov VV, Demin VA, Erokhin VV.

Sci Rep. 2019 Jul 25;9(1):10800. doi: 10.1038/s41598-019-47263-9.

5.

[Prion Properties of Alpha-Synuclein].

Schwarzman AL, Senkevich KA, Emelyanov AK, Pchelina SN.

Mol Biol (Mosk). 2019 May-Jun;53(3):380-387. doi: 10.1134/S0026898419030182. Review. Russian.

6.

DNA Damage Signaling-Induced Cancer Cell Reprogramming as a Driver of Tumor Relapse.

Filipponi D, Emelyanov A, Muller J, Molina C, Nichols J, Bulavin DV.

Mol Cell. 2019 May 16;74(4):651-663.e8. doi: 10.1016/j.molcel.2019.03.002. Epub 2019 Apr 3.

PMID:
30954402
7.

SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.

Emelyanov A, Kulabukhova D, Garaeva L, Senkevich K, Verbitskaya E, Nikolaev M, Andoskin P, Kopytova A, Milyukhina I, Yakimovskii A, Timofeeva A, Prakhova L, Ilves A, Vlasova I, Pchelina S.

J Neurol Sci. 2018 Dec 15;395:135-140. doi: 10.1016/j.jns.2018.10.002. Epub 2018 Oct 3.

PMID:
30316070
8.

Blood lysosphingolipids accumulation in patients with parkinson's disease with glucocerebrosidase 1 mutations.

Pchelina S, Baydakova G, Nikolaev M, Senkevich K, Emelyanov A, Kopytova A, Miliukhina I, Yakimovskii A, Timofeeva A, Berkovich O, Fedotova E, Illarioshkin S, Zakharova E.

Mov Disord. 2018 Aug;33(8):1325-1330. doi: 10.1002/mds.27393. Epub 2018 Sep 7.

PMID:
30192031
9.

Mutation analysis of Parkinson's disease genes in a Russian data set.

Emelyanov AK, Usenko TS, Tesson C, Senkevich KA, Nikolaev MA, Miliukhina IV, Kopytova AE, Timofeeva AA, Yakimovsky AF, Lesage S, Brice A, Pchelina SN.

Neurobiol Aging. 2018 Nov;71:267.e7-267.e10. doi: 10.1016/j.neurobiolaging.2018.06.027. Epub 2018 Jul 9.

PMID:
30146349
10.

Matrix Stiffening and EGFR Cooperate to Promote the Collective Invasion of Cancer Cells.

Grasset EM, Bertero T, Bozec A, Friard J, Bourget I, Pisano S, Lecacheur M, Maiel M, Bailleux C, Emelyanov A, Ilie M, Hofman P, Meneguzzi G, Duranton C, Bulavin DV, Gaggioli C.

Cancer Res. 2018 Sep 15;78(18):5229-5242. doi: 10.1158/0008-5472.CAN-18-0601. Epub 2018 Jul 19.

11.

Whole-Exome Sequencing in Searching for New Variants Associated With the Development of Parkinson's Disease.

Shulskaya MV, Alieva AK, Vlasov IN, Zyrin VV, Fedotova EY, Abramycheva NY, Usenko TS, Yakimovsky AF, Emelyanov AK, Pchelina SN, Illarioshkin SN, Slominsky PA, Shadrina MI.

Front Aging Neurosci. 2018 May 15;10:136. doi: 10.3389/fnagi.2018.00136. eCollection 2018.

12.

A voltage-dependent fluorescent indicator for optogenetic applications, archaerhodopsin-3: Structure and optical properties from in silico modeling.

Nikolaev DM, Emelyanov A, Boitsov VM, Panov MS, Ryazantsev MN.

Version 3. F1000Res. 2017 Jan 11 [revised 2017 Jan 1];6:33. doi: 10.12688/f1000research.10541.3. eCollection 2017.

13.

[The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].

Senkevich KA, Miliukhina IV, Beletskaia MV, Gracheva EV, Kudrevatykh AV, Nikolaev MA, Emelyanov AK, Kopytova AE, Timofeeva AA, Yakimovskii AF, Pchelina SN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):81-86. doi: 10.17116/jnevro201711710181-86. Russian.

PMID:
29171494
14.

Solvothermal synthesis of Sm3+-doped Fe3O4 nanoparticles.

Lastovina TA, Budnyk AP, Kudryavtsev EA, Nikolsky AV, Kozakov AT, Chumakov NK, Emelyanov AV, Soldatov AV.

Mater Sci Eng C Mater Biol Appl. 2017 Nov 1;80:110-116. doi: 10.1016/j.msec.2017.05.087. Epub 2017 May 14.

PMID:
28866144
15.

Phase separation drives heterochromatin domain formation.

Strom AR, Emelyanov AV, Mir M, Fyodorov DV, Darzacq X, Karpen GH.

Nature. 2017 Jul 13;547(7662):241-245. doi: 10.1038/nature22989. Epub 2017 Jun 21.

16.

Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci.

Aung T, Ozaki M, Lee MC, Schlötzer-Schrehardt U, Thorleifsson G, Mizoguchi T, Igo RP Jr, Haripriya A, Williams SE, Astakhov YS, Orr AC, Burdon KP, Nakano S, Mori K, Abu-Amero K, Hauser M, Li Z, Prakadeeswari G, Bailey JNC, Cherecheanu AP, Kang JH, Nelson S, Hayashi K, Manabe SI, Kazama S, Zarnowski T, Inoue K, Irkec M, Coca-Prados M, Sugiyama K, Järvelä I, Schlottmann P, Lerner SF, Lamari H, Nilgün Y, Bikbov M, Park KH, Cha SC, Yamashiro K, Zenteno JC, Jonas JB, Kumar RS, Perera SA, Chan ASY, Kobakhidze N, George R, Vijaya L, Do T, Edward DP, de Juan Marcos L, Pakravan M, Moghimi S, Ideta R, Bach-Holm D, Kappelgaard P, Wirostko B, Thomas S, Gaston D, Bedard K, Greer WL, Yang Z, Chen X, Huang L, Sang J, Jia H, Jia L, Qiao C, Zhang H, Liu X, Zhao B, Wang YX, Xu L, Leruez S, Reynier P, Chichua G, Tabagari S, Uebe S, Zenkel M, Berner D, Mossböck G, Weisschuh N, Hoja U, Welge-Luessen UC, Mardin C, Founti P, Chatzikyriakidou A, Pappas T, Anastasopoulos E, Lambropoulos A, Ghosh A, Shetty R, Porporato N, Saravanan V, Venkatesh R, Shivkumar C, Kalpana N, Sarangapani S, Kanavi MR, Beni AN, Yazdani S, Lashay A, Naderifar H, Khatibi N, Fea A, Lavia C, Dallorto L, Rolle T, Frezzotti P, Paoli D, Salvi E, Manunta P, Mori Y, Miyata K, Higashide T, Chihara E, Ishiko S, Yoshida A, Yanagi M, Kiuchi Y, Ohashi T, Sakurai T, Sugimoto T, Chuman H, Aihara M, Inatani M, Miyake M, Gotoh N, Matsuda F, Yoshimura N, Ikeda Y, Ueno M, Sotozono C, Jeoung JW, Sagong M, Park KH, Ahn J, Cruz-Aguilar M, Ezzouhairi SM, Rafei A, Chong YF, Ng XY, Goh SR, Chen Y, Yong VHK, Khan MI, Olawoye OO, Ashaye AO, Ugbede I, Onakoya A, Kizor-Akaraiwe N, Teekhasaenee C, Suwan Y, Supakontanasan W, Okeke S, Uche NJ, Asimadu I, Ayub H, Akhtar F, Kosior-Jarecka E, Lukasik U, Lischinsky I, Castro V, Grossmann RP, Sunaric Megevand G, Roy S, Dervan E, Silke E, Rao A, Sahay P, Fornero P, Cuello O, Sivori D, Zompa T, Mills RA, Souzeau E, Mitchell P, Wang JJ, Hewitt AW, Coote M, Crowston JG, Astakhov SY, Akopov EL, Emelyanov A, Vysochinskaya V, Kazakbaeva G, Fayzrakhmanov R, Al-Obeidan SA, Owaidhah O, Aljasim LA, Chowbay B, Foo JN, Soh RQ, Sim KS, Xie Z, Cheong AWO, Mok SQ, Soo HM, Chen XY, Peh SQ, Heng KK, Husain R, Ho SL, Hillmer AM, Cheng CY, Escudero-Domínguez FA, González-Sarmiento R, Martinon-Torres F, Salas A, Pathanapitoon K, Hansapinyo L, Wanichwecharugruang B, Kitnarong N, Sakuntabhai A, Nguyn HX, Nguyn GTT, Nguyn TV, Zenz W, Binder A, Klobassa DS, Hibberd ML, Davila S, Herms S, Nöthen MM, Moebus S, Rautenbach RM, Ziskind A, Carmichael TR, Ramsay M, Álvarez L, García M, González-Iglesias H, Rodríguez-Calvo PP, Fernández-Vega Cueto L, Oguz Ç, Tamcelik N, Atalay E, Batu B, Aktas D, Kasım B, Wilson MR, Coleman AL, Liu Y, Challa P, Herndon L, Kuchtey RW, Kuchtey J, Curtin K, Chaya CJ, Crandall A, Zangwill LM, Wong TY, Nakano M, Kinoshita S, den Hollander AI, Vesti E, Fingert JH, Lee RK, Sit AJ, Shingleton BJ, Wang N, Cusi D, Qamar R, Kraft P, Pericak-Vance MA, Raychaudhuri S, Heegaard S, Kivelä T, Reis A, Kruse FE, Weinreb RN, Pasquale LR, Haines JL, Thorsteinsdottir U, Jonasson F, Allingham RR, Milea D, Ritch R, Kubota T, Tashiro K, Vithana EN, Micheal S, Topouzis F, Craig JE, Dubina M, Sundaresan P, Stefansson K, Wiggs JL, Pasutto F, Khor CC.

Nat Genet. 2017 Jul;49(7):993-1004. doi: 10.1038/ng.3875. Epub 2017 May 29.

17.

A glucokinase gene mutation in a young boy with diabetes mellitus, hyperinsulinemia, and insulin resistance.

Emelyanov AO, Sechko E, Koksharova E, Sklyanik I, Kuraeva T, Mayorov A, Peterkova V, Dedov I.

Int Med Case Rep J. 2017 Mar 7;10:77-80. doi: 10.2147/IMCRJ.S125103. eCollection 2017.

18.

[THE PREVALENCE OF RESPIRATORY SYMPTOMS AMONG RESIDENTS OF THE RUSSIAN FAR NORTH].

Andronov SV, Lobanov AA, Popov AI, Emelyanov AV.

Klin Med (Mosk). 2017;95(3):260-3. Russian.

PMID:
30303360
19.

Thioredoxin-dependent disulfide bond reduction is required for protamine eviction from sperm chromatin.

Emelyanov AV, Fyodorov DV.

Genes Dev. 2016 Dec 15;30(24):2651-2656. doi: 10.1101/gad.290916.116. Epub 2016 Dec 28.

20.

p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis.

Brichkina A, Bertero T, Loh HM, Nguyen NT, Emelyanov A, Rigade S, Ilie M, Hofman P, Gaggioli C, Bulavin DV.

Genes Dev. 2016 Dec 1;30(23):2623-2636. doi: 10.1101/gad.290346.116.

21.

Dataset of total, oligomeric alpha-synuclein and hemoglobin levels in plasma in Parkinson׳s disease.

Emelyanov A, Andoskin P, Pchelina S.

Data Brief. 2016 Nov 28;10:182-185. eCollection 2017 Feb.

22.

Model acupuncture point: Bone marrow-derived stromal stem cells are moved by a weak electromagnetic field.

Emelyanov AN, Borisova MV, Kiryanova VV.

World J Stem Cells. 2016 Oct 26;8(10):342-354.

23.

Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.

Pchelina S, Emelyanov A, Baydakova G, Andoskin P, Senkevich K, Nikolaev M, Miliukhina I, Yakimovskii A, Timofeeva A, Fedotova E, Abramycheva N, Usenko T, Kulabukhova D, Lavrinova A, Kopytova A, Garaeva L, Nuzhnyi E, Illarioshkin S, Zakharova E.

Neurosci Lett. 2017 Jan 1;636:70-76. doi: 10.1016/j.neulet.2016.10.039. Epub 2016 Oct 22.

PMID:
27780739
24.

BEN domain protein Elba2 can functionally substitute for linker histone H1 in Drosophila in vivo.

Xu N, Lu X, Kavi H, Emelyanov AV, Bernardo TJ, Vershilova E, Skoultchi AI, Fyodorov DV.

Sci Rep. 2016 Sep 30;6:34354. doi: 10.1038/srep34354.

25.

[Expert Panel Resolution on Personified Choice of an Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Diseas].

Emelyanov AV, Avdeev SN, Aisanov ZR, Vizel AA, Ilina NI, Knyazheskaya NP, Leshchenko IV, Nenasheva NM, Styrt EA, Titova ON.

Ter Arkh. 2016;88(8):135-137. doi: 10.17116/terarkh2016888135-137. Russian. No abstract available.

PMID:
27636937
26.

[Mutation del 1,02kb in the CLN3 gene and extrapyramidal syndrome].

Nuzhnyi EP, Yakimovskii AF, Timofeeva AA, Usenko TS, Nikolaev MA, Emelyanov AK, Amosov VI, Bubnova EV, Boukina AM, Zakharova EY, Pchelina SN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(8):50-53. doi: 10.17116/jnevro20161168150-53. Russian.

PMID:
27635612
27.

Bright monomeric near-infrared fluorescent proteins as tags and biosensors for multiscale imaging.

Shcherbakova DM, Baloban M, Emelyanov AV, Brenowitz M, Guo P, Verkhusha VV.

Nat Commun. 2016 Aug 19;7:12405. doi: 10.1038/ncomms12405.

28.

Wip1 Controls Global Heterochromatin Silencing via ATM/BRCA1-Dependent DNA Methylation.

Filipponi D, Muller J, Emelyanov A, Bulavin DV.

Cancer Cell. 2016 Aug 8;30(2):361-362. doi: 10.1016/j.ccell.2016.07.016. Epub 2016 Aug 8. No abstract available.

29.

[SNCA rs356219 AND rs356165 VARIANTS ARE ASSOCIATED WITH PARKINSON'S DISEASE AND INCREASED ALPHA-SYNUCLEIN GENE EXPRESSION IN THE CD45(+)-BLOOD CELLS].

Emelyanov AK, Andoskin PA, Miliukhina IV, Timofeeva AA, Yakimovskii AF, Senkevich KA, Nikolaev MA, Pchelina SN.

Tsitologiia. 2016;58(2):99-104. Russian.

PMID:
27228655
30.

Independent Biological and Biochemical Functions for Individual Structural Domains of Drosophila Linker Histone H1.

Kavi H, Emelyanov AV, Fyodorov DV, Skoultchi AI.

J Biol Chem. 2016 Jul 15;291(29):15143-55. doi: 10.1074/jbc.M116.730705. Epub 2016 May 18.

31.

[Increase in GP IIb-IIIa and P2Y12 Receptors in Activated Platelets as the Possible Indicator of de novo Protein Synthesis].

Sirotkina OV, Laskovets AB, Andoskin PA, Emelyanov AK, Zabotina AM, Vavilova TV.

Mol Biol (Mosk). 2016 Jan-Feb;50(1):128-35. doi: 10.7868/S0026898416010183. Russian.

32.

Minimal domain of bacterial phytochrome required for chromophore binding and fluorescence.

Rumyantsev KA, Shcherbakova DM, Zakharova NI, Emelyanov AV, Turoverov KK, Verkhusha VV.

Sci Rep. 2015 Dec 18;5:18348. doi: 10.1038/srep18348.

33.

Plasma oligomeric alpha-synuclein is associated with glucocerebrosidase activity in Gaucher disease.

Nuzhnyi E, Emelyanov A, Boukina T, Usenko T, Yakimovskii A, Zakharova E, Pchelina S.

Mov Disord. 2015 Jun;30(7):989-91. doi: 10.1002/mds.26200. Epub 2015 May 12.

PMID:
25962734
34.

A Multifunctional Mutagenesis System for Analysis of Gene Function in Zebrafish.

Quach HN, Tao S, Vrljicak P, Joshi A, Ruan H, Sukumaran R, Varshney GK, LaFave MC; Ds Screen Team, Burgess SM, Winkler C, Emelyanov A, Parinov S, Sampath K.

G3 (Bethesda). 2015 Apr 2;5(6):1283-99. doi: 10.1534/g3.114.015842.

35.

Photomodulation of proliferation and differentiation of stem cells by the visible and infrared light.

Emelyanov AN, Kiryanova VV.

Photomed Laser Surg. 2015 Mar;33(3):164-74. doi: 10.1089/pho.2014.3830. Epub 2015 Feb 18. Review.

PMID:
25692649
36.

[Severe asthma: Characteristics of patients in clinical practice].

Sergeeva GR, Emelyanov AV, Korovina OV, Znakhurenko AA, Leshenkova EV, Kozyreva LV, Asatiani N.

Ter Arkh. 2015;87(12):26-31. doi: 10.17116/terarkh2015871226-31. Russian.

PMID:
26978414
37.

Wip1 phosphatase in breast cancer.

Emelyanov A, Bulavin DV.

Oncogene. 2015 Aug 20;34(34):4429-38. doi: 10.1038/onc.2014.375. Epub 2014 Nov 10. Review.

PMID:
25381821
38.

Increased plasma oligomeric alpha-synuclein in patients with lysosomal storage diseases.

Pchelina SN, Nuzhnyi EP, Emelyanov AK, Boukina TM, Usenko TS, Nikolaev MA, Salogub GN, Yakimovskii AF, Zakharova EY.

Neurosci Lett. 2014 Nov 7;583:188-93. doi: 10.1016/j.neulet.2014.09.041. Epub 2014 Sep 26.

PMID:
25265039
39.

Drosophila TAP/p32 is a core histone chaperone that cooperates with NAP-1, NLP, and nucleophosmin in sperm chromatin remodeling during fertilization.

Emelyanov AV, Rabbani J, Mehta M, Vershilova E, Keogh MC, Fyodorov DV.

Genes Dev. 2014 Sep 15;28(18):2027-40. doi: 10.1101/gad.248583.114.

40.

Drosophila linker histone H1 coordinates STAT-dependent organization of heterochromatin and suppresses tumorigenesis caused by hyperactive JAK-STAT signaling.

Xu N, Emelyanov AV, Fyodorov DV, Skoultchi AI.

Epigenetics Chromatin. 2014 Jul 28;7:16. doi: 10.1186/1756-8935-7-16. eCollection 2014.

41.

Xmrk, kras and myc transgenic zebrafish liver cancer models share molecular signatures with subsets of human hepatocellular carcinoma.

Zheng W, Li Z, Nguyen AT, Li C, Emelyanov A, Gong Z.

PLoS One. 2014 Mar 14;9(3):e91179. doi: 10.1371/journal.pone.0091179. eCollection 2014.

42.

Wip1 controls global heterochromatin silencing via ATM/BRCA1-dependent DNA methylation.

Filipponi D, Muller J, Emelyanov A, Bulavin DV.

Cancer Cell. 2013 Oct 14;24(4):528-41. doi: 10.1016/j.ccr.2013.08.022. Erratum in: Cancer Cell. 2016 Aug 8;30(2):361-362.

43.

SNCA, LRRK2, MAPT polymorphisms and Parkinson's disease in Russia.

Emelyanov A, Andoskin P, Yakimovskii A, Usenko T, Nuzhnyi E, Nikolaev M, Pchelina S.

Parkinsonism Relat Disord. 2013 Nov;19(11):1064-5. doi: 10.1016/j.parkreldis.2013.06.003. Epub 2013 Jul 3. No abstract available.

PMID:
23830801
44.

Drosophila H1 regulates the genetic activity of heterochromatin by recruitment of Su(var)3-9.

Lu X, Wontakal SN, Kavi H, Kim BJ, Guzzardo PM, Emelyanov AV, Xu N, Hannon GJ, Zavadil J, Fyodorov DV, Skoultchi AI.

Science. 2013 Apr 5;340(6128):78-81. doi: 10.1126/science.1234654.

45.

Identification and characterization of ToRC, a novel ISWI-containing ATP-dependent chromatin assembly complex.

Emelyanov AV, Vershilova E, Ignatyeva MA, Pokrovsky DK, Lu X, Konev AY, Fyodorov DV.

Genes Dev. 2012 Mar 15;26(6):603-14. doi: 10.1101/gad.180604.111.

46.

Reduced content of α-synuclein in peripheral blood leukocytes of patients with LRRK2-associated Parkinson's disease.

Pchelina SN, Emelyanov AK, Yakimovskii AF, Miller DW, Shabalina IG, Drozdova AS, Schwarzman AL.

Bull Exp Biol Med. 2011 Apr;150(6):679-81.

PMID:
22235415
47.

Glucocerebrosidase gene mutations are associated with Parkinson's disease in Russia.

Emelyanov A, Boukina T, Yakimovskii A, Usenko T, Drosdova A, Zakharchuk A, Andoskin P, Dubina M, Schwarzman A, Pchelina S.

Mov Disord. 2012 Jan;27(1):158-9. doi: 10.1002/mds.23950. Epub 2011 Sep 13. No abstract available.

PMID:
21915911
48.

An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening.

Nguyen AT, Emelyanov A, Koh CH, Spitsbergen JM, Parinov S, Gong Z.

Dis Model Mech. 2012 Jan;5(1):63-72. doi: 10.1242/dmm.008367. Epub 2011 Sep 8.

49.

Asthma programmes in diverse regions of the world: challenges, successes and lessons learnt.

Lalloo UG, Walters RD, Adachi M, de Guia T, Emelyanov A, Fritscher CC, Hong J, Jimenez C, King GG, Lin J, Loaiza A, Nadeau G, Neffen H, Sekerel BE, Yorgancioğlu A, Zar HJ.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1574-87. doi: 10.5588/ijtld.11.0289. Epub 2011 Sep 2.

PMID:
21888756
50.

A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish.

Nguyen AT, Emelyanov A, Koh CH, Spitsbergen JM, Lam SH, Mathavan S, Parinov S, Gong Z.

Dis Model Mech. 2011 Nov;4(6):801-13. doi: 10.1242/dmm.007831. Epub 2011 Jul 4.

Supplemental Content

Loading ...
Support Center